Vaccine Director, Japan Real-World Evidence & Health Outcomes Research

The Director of Real-World Evidence & Health Outcomes Research at GSK will lead the local evidence strategy for innovative medicines and vaccines in Japan. This role requires a strong understanding of the Japanese healthcare system and involves strategic leadership, evidence generation, and collaboration with cross-functional teams. The ideal candidate will have over 8 years of experience in RWE, HEOR, or Market Access, along with advanced degrees in relevant fields. Business-level proficiency in Japanese and English is essential. Compensation details are not specified. The Director of Real-World Evidence & Health Outcomes Research at GSK will lead the local evidence strategy for innovative medicines and vaccines in Japan. This role requires a strong understanding of the Japanese healthcare system and involves strategic leadership, evidence generation, and collaboration with cross-functional teams. The ideal candidate will have over 8 years of experience in RWE, HEOR, or Market Access, along with advanced degrees in relevant fields. Business-level proficiency in Japanese and English is essential.

Position Summary

At GSK, we are uniting science, technology, and talent to get ahead of disease together. The Director of RWE-HO Japan leads the local evidence strategy of a dedicated therapeutic area (TA) to demonstrate the value of GSK’s innovative medicines/ vaccines. This role ensures local real-world clinical, economic and humanistic evidence supports regulatory, reimbursement, and patient access objectives, while guiding a high-performing team aligned with GSK’s global evidence standards and Japan’s payer environment.

Key ResponsibilitiesStrategic Leadership

• Partner with Medical team for robust gap assessment to better understand local unmet needs.
• Participate in Global DGTs and co-create global DGPs representing interests of Japan market needs.
• With solid understanding of the Japan health care system and policy landscape, develop and implement forward-looking Japan-specific RWE and HEOR strategies across GSK’s priority therapeutic areas (e.g., specialty/ oncology/ vaccines/ respiratory) for addressing evidential gaps.
• Identify and address capability gaps to prepare teams for future competitive advantage.
• Ensure evidence supports product value propositions across the lifecycle, including but not limited to optimal listing, re-pricing, HTA engagement, post launch re-examination and outcomes demonstration aligned with GSK's patient and access goals.

Evidence Generation & Execution

• Ensure that team members engage closely with Japan and global cross-functional stakeholders to plan, design and execute data generation plans (DGPs) for priority assets.
• Lead/ drive prioritised local RWE and Health Outcomes studies, as well as local adaptation of global economic models and support CEE/ HTA submission planning and execution.
• Oversee publications and presentations of study findings at national and international forums.

Cross-Functional Collaboration

• Partner with Market Access, Government Affairs, Medical, Regulatory, and Commercial teams to ensure evidence is aligned with brand strategy and payer needs.
• Represent Japan in global data generation working groups to ensure country insights inform development-stage and post-launch evidence plans.

External Engagement

• Cultivate partnerships with academic institutions, KOLs, and data providers in Japan.
• Contribute to scientific, payer and HTA engagement by translating evidence into clear, locally relevant value messages.

Team & Capability Development

• Manage, mentor, and develop a team of RWE/HEOR professionals.
• Build functional excellence and capability in evidence generation, study design, value communication, and policy awareness.
• Foster a culture of scientific integrity, innovation, and collaboration.

Qualifications

• Advanced degree in science, epidemiology, health economics, public health, biostatistics, or related discipline.
• 8+ years of experience in RWE, HEOR, or Market Access within Japan’s pharmaceutical, biotech, or consulting environment.
• Knowledgeable of Japan’s HTA system, Chuikyo processes, and healthcare policy landscape.
• Proven experience designing and delivering impactful RWE/HEOR projects in Japan (regional/ global experience a plus).
• Track record of team leadership, coaching, and talent development.
• Business-level Japanese and English proficiency.
• Strategic mindset with strong communication and collaboration skills.
• Alignment with GSK values: patient focus, integrity, transparency, and respect.

Why GSK?Uniting science, technology and talent to get ahead of disease together.

GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale.

People and patients around the world count on the medicines and vaccines we make, so we’re committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.

We are committed to creating an inclusive workplace and providing equal opportunities for all applicants. We embrace an agile working culture across our roles, so if flexibility is important to you please discuss opportunities with our hiring team. If you need any adjustments to the recruitment process to help you demonstrate your strengths and capabilities, contact APACRecruitment.Adjustments@gsk.com. Please note this email is for adjustment requests only; for other enquiries please use our standard contact channels.

Important notice to Employment businesses/ Agencies

GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.

• Position Summary At GSK, we are uniting science, technology, and talent to get ahead of disease together. The Director of RWE-HO Japan leads the local evidence strategy of a dedicated therapeutic area Responsibilities
• Lead the local evidence strategy for GSK’s innovative medicines and vaccines in Japan.
• Develop and implement Japan-specific RWE and HEOR strategies across priority therapeutic areas.
• Ensure evidence supports product value propositions throughout the lifecycle.
• Engage with cross-functional stakeholders to plan and execute data generation plans.
• Cultivate partnerships with academic institutions and data providers in Japan. Skills
• Real-World Evidence
• Health Economics
• Market Access
• Data Generation Plans
• Epidemiology
• Biostatistics
• Team Leadership
• Stakeholder Engagement
• Strategic Planning
• Cross-Functional Collaboration
• Communication Skills
• Policy Awareness
• Japanese Proficiency Education
• An advanced degree in science, epidemiology, health economics, public health, biostatistics, or a related discipline is required.